-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
【Chemical Machinery and Equipment Network Market Analysis】The domestic pharmaceutical equipment industry, which has accelerated the pace of import substitution, is showing stronger development resilience
.
According to data previously released by China Insights Consulting, the current scale of the global pharmaceutical equipment industry exceeds 500 billion yuan, and it will exceed 700 billion yuan
in 2025.
In the Chinese market, its scale has approached 100 billion yuan, and it is expected to reach 200 billion yuan
by 2025.
.
According to data previously released by China Insights Consulting, the current scale of the global pharmaceutical equipment industry exceeds 500 billion yuan, and it will exceed 700 billion yuan
in 2025.
In the Chinese market, its scale has approached 100 billion yuan, and it is expected to reach 200 billion yuan
by 2025.
The epidemic has accelerated the process of import substitution of domestic pharmaceutical machines
.
Due to the delay in the delivery of imported equipment, pharmaceutical companies have turned their attention to domestic domestic pharmaceutical manufacturers
with strength.
Compared with the past, domestic pharmaceutical machinery enterprises in recent years through continuous strengthening of technical research and continuous increase in research and development investment, some equipment performance has been comparable to imported equipment, coupled with domestic pharmaceutical machinery enterprises have the advantages of fast delivery, high after-sales service level, including Chutian Technology, Dongfulong and other head enterprises are actively embracing new opportunities, orders have increased significantly
.
It is not difficult to speculate that in the post-epidemic era, the situation of slow import substitution of domestic pharmaceutical machines will change, and more pharmaceutical products are expected to cut into overseas markets, enhance their recognition and share in overseas markets, and the growth of the domestic pharmaceutical machinery market can be expected
in the future.
.
Due to the delay in the delivery of imported equipment, pharmaceutical companies have turned their attention to domestic domestic pharmaceutical manufacturers
with strength.
Compared with the past, domestic pharmaceutical machinery enterprises in recent years through continuous strengthening of technical research and continuous increase in research and development investment, some equipment performance has been comparable to imported equipment, coupled with domestic pharmaceutical machinery enterprises have the advantages of fast delivery, high after-sales service level, including Chutian Technology, Dongfulong and other head enterprises are actively embracing new opportunities, orders have increased significantly
.
It is not difficult to speculate that in the post-epidemic era, the situation of slow import substitution of domestic pharmaceutical machines will change, and more pharmaceutical products are expected to cut into overseas markets, enhance their recognition and share in overseas markets, and the growth of the domestic pharmaceutical machinery market can be expected
in the future.
It is worth mentioning that how to seize the opportunities and challenges brought by the changes in the pharmaceutical machine market is a problem
that pharmaceutical machine people have to face.
Compared with imported pharmaceutical machines, domestic pharmaceutical machines have a weak technology due to the late start of the industry, but it is undeniable that after years of development and technology accumulation, coupled with the promotion of new medical reform policies such as consistency evaluation, centralized procurement, and medical insurance in recent years, it has forced upstream pharmaceutical equipment to accelerate the transformation and upgrading, and the level of domestic pharmaceutical machines is constantly improving
.
that pharmaceutical machine people have to face.
Compared with imported pharmaceutical machines, domestic pharmaceutical machines have a weak technology due to the late start of the industry, but it is undeniable that after years of development and technology accumulation, coupled with the promotion of new medical reform policies such as consistency evaluation, centralized procurement, and medical insurance in recent years, it has forced upstream pharmaceutical equipment to accelerate the transformation and upgrading, and the level of domestic pharmaceutical machines is constantly improving
.
At the same time, the policy side and the demand side also bring more possibilities
to the drug machine industry.
Among them, on the policy side, the high-end pharmaceutical equipment industry is ushering in policy encouragement and support, and the gradual improvement of pharmaceutical industry standards and stricter supervision have forced the industry to update and upgrade in the direction of automation and intelligence, and the pharmaceutical equipment industry, as the "mother machine" of pharmaceutical production, will play a more important role
in improving the domestic pharmaceutical level.
On the demand side, with the aging of the population and the continuous upgrading of consumption, the rapid development of biological drugs, innovative drugs and pharmaceutical outsourcing markets will bring impetus
to the expansion of demand for pharmaceutical equipment market.
to the drug machine industry.
Among them, on the policy side, the high-end pharmaceutical equipment industry is ushering in policy encouragement and support, and the gradual improvement of pharmaceutical industry standards and stricter supervision have forced the industry to update and upgrade in the direction of automation and intelligence, and the pharmaceutical equipment industry, as the "mother machine" of pharmaceutical production, will play a more important role
in improving the domestic pharmaceutical level.
On the demand side, with the aging of the population and the continuous upgrading of consumption, the rapid development of biological drugs, innovative drugs and pharmaceutical outsourcing markets will bring impetus
to the expansion of demand for pharmaceutical equipment market.
However, the domestic pharmaceutical equipment industry still faces some challenges, the main challenges include low industry concentration, serious homogeneous competition, and talent shortage
.
The concentration of the pharmaceutical equipment industry has always been relatively low, and there are only a few listed companies in the market at present, such as Chutian and Dongfulong, and the homogeneous competition of small and medium-sized enterprises is serious, and it is inevitable to fall into a low-level low-price war
.
The analysis of the reasons for the low overall industry level and lack of innovation of domestic pharmaceutical machines is mainly related to the shortage of
talents.
Pharmaceutical equipment industry is a complex discipline, both to understand medicine, but also to understand equipment, and need industry technology innovation developers to keep up with the trend of intelligence, automation, the current market can meet the needs of pharmaceutical enterprises compound talent is very short, and mostly to enterprises independent training, how to make up for the industry talent shortcoming in the future is a major challenge
.
.
The concentration of the pharmaceutical equipment industry has always been relatively low, and there are only a few listed companies in the market at present, such as Chutian and Dongfulong, and the homogeneous competition of small and medium-sized enterprises is serious, and it is inevitable to fall into a low-level low-price war
.
The analysis of the reasons for the low overall industry level and lack of innovation of domestic pharmaceutical machines is mainly related to the shortage of
talents.
Pharmaceutical equipment industry is a complex discipline, both to understand medicine, but also to understand equipment, and need industry technology innovation developers to keep up with the trend of intelligence, automation, the current market can meet the needs of pharmaceutical enterprises compound talent is very short, and mostly to enterprises independent training, how to make up for the industry talent shortcoming in the future is a major challenge
.
In the face of a market space of hundreds of billions of yuan, pharmaceutical machinery enterprises need both internal and external repair, a better environment and policy support externally, and a strengthening of the core competitiveness of enterprises internally
.
.
On the one hand, the pharmaceutical equipment industry also needs more favorable policy support, such as in terms of talents, more measures can be given to strengthen talent training and improve the status and treatment of pharmaceutical operators; In terms of R&D innovation, more policies to encourage the innovation of pharmaceutical machine enterprises have been introduced, and support for R&D investment enterprises in terms of funds
.
.
On the other hand, pharmaceutical machinery enterprises cultivate the "hard core" of domestic demand, including attaching importance to the strength of talent teams, strengthening R&D and innovation, etc.
, and grasp the new direction and constantly transform and upgrade
under the trend of intelligence, automation and continuity.
At the same time, energy saving and consumption reduction is also the trend of the development of the pharmaceutical machine industry, and pharmaceutical enterprises need to actively respond to the call and invest in the development and development of environmentally friendly pharmaceutical machines to meet the new needs
of the market.
In addition, in terms of the internationalization of the layout, on the basis of excellent equipment performance, fast delivery speed and timely after-sales service, pharmaceutical enterprises also need to continuously improve their service level and have an in-depth understanding of the policies, supervision and other aspects of the target market, in order to better cut into the target market
.
, and grasp the new direction and constantly transform and upgrade
under the trend of intelligence, automation and continuity.
At the same time, energy saving and consumption reduction is also the trend of the development of the pharmaceutical machine industry, and pharmaceutical enterprises need to actively respond to the call and invest in the development and development of environmentally friendly pharmaceutical machines to meet the new needs
of the market.
In addition, in terms of the internationalization of the layout, on the basis of excellent equipment performance, fast delivery speed and timely after-sales service, pharmaceutical enterprises also need to continuously improve their service level and have an in-depth understanding of the policies, supervision and other aspects of the target market, in order to better cut into the target market
.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.
to anyone.
